Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol.

Journal: BMJ open gastroenterology
Published Date: Dec 11, 2023

Abstract

INTRODUCTION: Inflammatory bowel diseases (IBD) are immune-mediated conditions that are increasing in incidence and prevalence worldwide. Their assessment and monitoring are becoming increasingly important, though complex. The best disease control is achieved through tight monitoring of objective inflammatory parameters (such as serum and stool inflammatory markers), cross-sectional imaging and endoscopic assessment. Considering the complexity of the information obtained throughout a patient's journey, artificial intelligence (AI) provides an ideal adjunct to existing tools to help diagnose, monitor and predict the course of disease of patients with IBD. Therefore, we propose a scoping review assessing AI's role in diagnosis, monitoring and prognostication tools in patients with IBD. We aim to detect gaps in the literature and address them in future research endeavours.

Authors

  • Mallory Chavannes
    Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Los Angeles, Los Angeles, California, USA mchavannes@chla.usc.edu.
  • Lynn Kysh
    Departments of Anesthesiology, Pediatrics, and Psychiatry & Behavioral Sciences, University of Southern California, Keck School of Medicine.
  • Mariangela Allocca
    Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milano, Lombardia, Italy.
  • Noa Krugliak Cleveland
    Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
  • Michael Todd Dolinger
    Division of Pediatric Gastroenterology, Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai, New York, New York, USA.
  • Tom S Robbins
    Motilent Ltd, London, UK.
  • David T Rubin
    Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
  • Shintaro Sagami
    Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan.
  • Bram Verstockt
    Department of Chronic Diseases and Metabolism (CHROMETA), Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
  • Kerri Novak
    Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.

Keywords

External Resources

Popular Topics
Recent Journals